Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-29 20:00:03 - browse：51755

Purple AML cells in blood flow — coverage from STAT — Acute myeloid leukemia cells amid blood flow. Adobe

The Food and Drug Administration issued a change to the warning label for Legend Biotech and Janssen’s myeloma CAR-T, Carvykti or cilta-cel, adding that some secondary blood cancers have occurred following treatment for multiple myeloma with the cell therapy.

While the label means that physicians will have to have a conversation about secondary malignancies occurring after Carvykti treatment, oncologists and CAR-T experts said the label update won’t change anything about the use of Carvykti.

“I do not believe this particular change will have any bearing on patient care,” said Saad Usmani, a myeloma physician and cell therapist at Memorial Sloan Kettering who has also studied Carvykti. That’s partly because physicians already discuss the risk of second cancers due to other cancer therapies including radiation, some targeted therapies, and some chemotherapies, which are necessary in the use of CAR-T. “We do have secondary primary malignancy discussions with patients in the context of transplant and will have to do for CAR-T as well,” Usmani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： There's no autism epidemic. It's an autism diagnosis epidemic

focus

WSS

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Eliminate the waiting period for sterilization covered by Medicaid

Caregivers of transplant patients call for more support, training

Abortion pill Supreme Court ruling could impact entire drug industry

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Why the world’s most expensive drug might be worth the price

entertainment

Wikipedia

focus

Jerome Adams on the need for new antivirals for Covid

As JPM 2024 winds down, some health tech firms project optimism

DIEP, the 'gold standard' of breast reconstruction, is under threat

Readout LOUD podcast: mifepristone case, GLP

Walensky prepares to leave CDC — and Congress — behind

New England Journal of Medicine addresses racist history, slavery

After affirmative action ruling, medical educators look to 'holistic review'

Readout LOUD podcast: live from JPM 2024

BioMarin wins approval for gene therapy to treat hemophilia A

Readout LOUD podcast: mifepristone case, GLP

entertainment

HHS names first

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Three issues to watch in global health in 2024

Designating disabled people as health disparity population is crucial

Idaho abortion case may prompt more restrictions in other states

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

Wikipedia

focus

hotspot

knowledge